Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2004
03/04/2004WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
03/04/2004WO2004017895A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells
03/04/2004WO2004017816A2 Methods for diagnosing dementia-related neurological disorders
03/04/2004WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof
03/04/2004WO2004017728A2 Methods
03/04/2004WO2004017727A1 A method of treatment and prophylaxis
03/04/2004WO2004005554A3 Antisense modulation of livin expression
03/04/2004WO2004001420A3 Method and reagent for specifically identifying and quantifying one or more proteins in a sample
03/04/2004WO2004001010A3 METHODS FOR IDENTIFYING SMALL MOLECULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY
03/04/2004WO2004000229A3 Treatment of human multiple myeloma by curcumin
03/04/2004WO2003104476A3 Assay to detect replication competent viruses
03/04/2004WO2003102578A3 High throughput cellular response assay using microarrays
03/04/2004WO2003097871A8 Marker molecules associated with lung tumors
03/04/2004WO2003097856A3 Plating media
03/04/2004WO2003096014A3 Magneto-controlled method and system for determining an analyte in a liquid medium
03/04/2004WO2003087388A3 Bioluminescence regenerative cycle (brc) for nucleic acid quantification
03/04/2004WO2003084480A3 HAUSP-p53 INTERACTION AND USES THEREOF
03/04/2004WO2003083485A3 Protein for use in hypoxia related conditions
03/04/2004WO2003082216A9 Neuroprotectant methods, compositions, and screening methods thereof
03/04/2004WO2003079996A3 Process for preparing purified s-bel and r-bel and compositions thereof
03/04/2004WO2003078603A3 Strong gene sets for glioma classification
03/04/2004WO2003073107A3 Neuropeptide receptor and uses thereof
03/04/2004WO2003072787A3 Method for detection of leptin receptor ligands
03/04/2004WO2003070901A3 Heat stable mutants of starch biosynthesis enzymes
03/04/2004WO2003066903A3 Genetic markers for bone mass
03/04/2004WO2003065871A3 Methods and compositions for treating hematological disorders
03/04/2004WO2003064679A3 Methods for detecting vancomycin-resistant microorganisms and compositions therefor
03/04/2004WO2003062464A3 Major virulence factor detection and verocytotoxin type 2 subtype from clinical e. coli isolates using a one-step multiplex pcr
03/04/2004WO2003062446A9 Mrp9 and its use detecting and treating cancer
03/04/2004WO2003062372A3 Nanoparticle assembled hollow spheres
03/04/2004WO2003059256A3 Genes overexpresses by ovarian cancer and their use in developing novel therapeutics especially antibodies
03/04/2004WO2003058239A3 Test strip for determining concentration of triglycerides
03/04/2004WO2003057832A3 Identification of genes controlling complex traits
03/04/2004WO2003055980A3 Il-17 like molecules and uses thereof
03/04/2004WO2003050311A3 Methods and compositions for diagnosing and treating hypotrichosis simplex
03/04/2004WO2003050300A3 Diagnosis and treatment of cancer
03/04/2004WO2003045988A3 Method to isolate genes involved in aging
03/04/2004WO2003044211A3 Materials and methods for releasing genetic material
03/04/2004WO2003040409A9 Novel germinal center kinase proteins, compositions, and methods of use
03/04/2004WO2003040407A3 Novel markers for cardiopathies
03/04/2004WO2003037267A3 Compositions and methods for the therapy and diagnosis of lung cancer
03/04/2004WO2003032108A3 Confirmation sequencing
03/04/2004WO2003029485A3 Specific differential display arrays
03/04/2004WO2003025213A3 Yeast proteome analysis
03/04/2004WO2003023571A3 Methods for differential cell counts including related apparatus and software for performing same
03/04/2004WO2003020970A3 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
03/04/2004WO2003019198A3 Methods relating to treatment of atherosclerosis
03/04/2004WO2003019196A3 Diagnosis and treatment of atherosclerosis
03/04/2004WO2003012108A3 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds
03/04/2004WO2003012034A9 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/04/2004WO2003008624A3 Nucleic acid amplification using nicking agents
03/04/2004WO2003001176A3 Gedap method (genotyping based on diagnostic amplification products) for detecting and/or preventing genotyping errors from amplification products of a polymorphic locus
03/04/2004WO2003000846A3 A novel g protein-coupled receptor, gave 3
03/04/2004WO2002103052B1 Amplifiable probe
03/04/2004WO2002085791A3 Pcr-based monitoring in wastewater biotreatment systems
03/04/2004WO2002082091A3 Method for identification of proteins from intracellular bacteria
03/04/2004WO2002079495A3 Genomics applications for modified oligonucleotides
03/04/2004WO2002079477A3 Biosynthetic genes for butenyl-spinosyn insecticide production
03/04/2004WO2002074918A3 T-cell polynucleotides and polypeptides
03/04/2004WO2002050310A3 Rolling circle amplification detection of rna and dna
03/04/2004WO2002044424A9 Compositions, methods, apparatus and products comprising a stathmin/oncoprotein 18 sequence for detecting and treating cancer
03/04/2004WO2002038540A9 Activity-dependent cysteine protease profiling reagent
03/04/2004WO2002020762A8 Tnf receptor-like molecules and uses thereof
03/04/2004WO2002002811B1 Method for controlling the microbiological quality of an aqueous medium and kit therefor
03/04/2004WO2001073123B1 Nanoparticles having oligonucleotides attached thereto and uses therefor
03/04/2004WO2001057276A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
03/04/2004US20040045046 Transgenic mammals expressing polyglutamine
03/04/2004US20040045043 Comprises expression vectors for generating transgenic animal models for screening drugs and treating obesity and cardiovascular disorders
03/04/2004US20040044194 Aggrecanase molecules
03/04/2004US20040044192 Genetic engineered polypeptide; diagnosis of Lyme disease
03/04/2004US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases
03/04/2004US20040043956 Hybrid nucleic acid; skin disorders; antiinflammatory agents
03/04/2004US20040043953 Genetic engineering; culture product
03/04/2004US20040043950 Oligonucleotide antibodies; anticancer agents; measurement gene expression in sample; calibration
03/04/2004US20040043941 Antiinflamamtory agents; autoimmune disease; anticancer agents
03/04/2004US20040043929 Novel proteins and nucleic acids encoding same
03/04/2004US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders
03/04/2004US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer
03/04/2004US20040043923 Detection, calibration binding of ligand to nucleic acids
03/04/2004US20040043908 Railroad wheels; friction resistance; mixture containing binder, extreme pressure lubricant and oil
03/04/2004US20040043494 Apparatus for studying arrays
03/04/2004US20040043477 Apparatus for monitoring blood sugar, urea, lactate, cholesterol, vitamins, troponin and myoglobin concentrations in bodily fluids
03/04/2004US20040043471 Production of chimeric human papillomavirus
03/04/2004US20040043467 Supracolonic aerodigestive neoplasm detection
03/04/2004US20040043453 Process for trapping and confining microorganisms in air using water-soluble polymers
03/04/2004US20040043443 System, method and apparatus for the rapid detection and analysis of airborne biological agents
03/04/2004US20040043441 Methods of quantifying methotrexate metabolites
03/04/2004US20040043439 Luciferase detection reagent kits and luciferase detection method using the kit
03/04/2004US20040043434 Shp-2 tyrosine phosphatase and embryonic stem cell differentiation
03/04/2004US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified
03/04/2004US20040043425 Screening, detecting and/or prognosing respiratory system disorders; bronchodilator agents
03/04/2004US20040043422 Detection
03/04/2004US20040043416 Using oligonucleotide ligation assay to identify restriction fragment lenth polymorphisms; high throughput assay for genotyping blood and bodily fluids and tissues
03/04/2004US20040043415 Comprises nucleotide sequences coding heat resistant synthetase for use as replication tool in genetic engineering and molecular cloning
03/04/2004US20040043414 Nucleic acid encoding bacillus stearothermophilus tau polymerase subunit
03/04/2004US20040043411 DSP-11 dual-specificity phosphatase
03/04/2004US20040043410 Methods for testing for and inhibiting the development of Huntington's disease
03/04/2004US20040043409 Identification of a region of the major surface glycoprotein (MSG) gene of human Pneumocystis carinii
03/04/2004US20040043408 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
03/04/2004US20040043406 Reagents and methods useful for detecting diseases of the gastrointestinal tract